Table 2.
Equivalence test for primary outcomes.
T0 blood loss |
log (T0 blood loss) |
TOST | |||
---|---|---|---|---|---|
Mean | 95% CI | Mean | 95% CI | ||
Synthetic oxytocin (n = 127) | 269.12 | 219.39–318.84 | 5.19 | 5.03–5.35 | Test for difference |
Tranexamic acid (n = 104) | 263.88 | 215.25–312.52 | 5.19 | 5.02–5.37 | H0: no difference (diff = 0) |
p-value >0.05 (not rejected) | |||||
Overall (n = 231) | 266.76 | 231.99–301.53 | 5.19 | 5.07–5.31 | |
Test for equivalence | |||||
Difference | 5.23 | −64.81 to 75.28 | 0.00 | −0.24 to 0.24 | H0: no equivalence (|θ| ≥ Δ) |
p-value <0.05 (rejected) | |||||
p-value for normality | <0.001 (not normal) | >0.05 (normal) | |||
Equivalence limits (Δ) | 150 mL | 5.01 (log units) | Conclusion: equivalence | ||
T0 blood loss |
log (T0 blood loss) |
TOST | |||
---|---|---|---|---|---|
Mean | 95% CI | Mean | 95% CI | ||
Synthetic oxytocin (n = 119) | 397.66 | 334.36–460.96 | 5.68 | 5.54–5.82 | Test for difference |
Tranexamic acid (n = 91) | 405.64 | 344.23–467.04 | 5.75 | 5.59–5.90 | H0: no difference (diff = 0) |
p-value >0.05 (not rejected) | |||||
Overall (n = 210) | 401.12 | 356.81–445.43 | 5.71 | 5.61–5.81 | |
Test for equivalence | |||||
Difference | −7.97 | −97.61 to 81.66 | −0.07 | −0.27 to 0.14 | H0: no equivalence (|θ| ≥ Δ) |
p-value <0.05 (rejected) | |||||
p-value for normality | <0.001 (not normal) | >0.05 (normal) | |||
Equivalence limits (Δ) | 150 mL | 5.01 (log units) | Conclusion: equivalence |